Evaluation of antimicrobial usage vs. susceptibility relationships typically involves single agents. However, susceptibility profiles may be affected by multiple drugs. From 1992 through 1996, we studied relationships between drug usage and the susceptibility (only susceptibility rates of §70%) of Acinetobacter anitratus (baumannii), Enterobacter aerogenes, Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, and Serratia marcescens to 22 agents. Linear regression was used to assess usage of each agent vs. susceptibility to it and to all agents. Only relationships with a coefficient of determination of §0.5 and a negative slope were evaluated and classified as increasing drug use and decreasing susceptibility (FD, f%S) or decreasing drug use and increasing susceptibility (fD, F%S). The mean numbers (range) of drugs associated with a change in susceptibility were 1.7 (0 -14) and 0.6 (0 -7), respectively, for FD, f%S and fD, F%S relationships. Multiple antimicrobials are associated with susceptibility to other drugs; thus, surveillance of these relationships should not be limited to single drugs.
The emergence of resistance to antimicrobials was detected in susceptibility for the antimicrobial/organism of interest, indicating that the usage of multiple antimicrobials should not be soon after their introduction, and the current rate of resistance to a large number of antimicrobials is alarming [1 -6] . Although ignored when susceptibility trends are evaluated. Thus, the objective of this study was to evaluate the impact of the usage many factors have been implicated as contributing to this increase, the selective pressures exerted by widespread and indisof a variety of antimicrobials on changes in susceptibility of common nosocomial gram-negative aerobes. criminate antibiotic usage are often cited as a major factor [2, 7 -10] . Despite this assumption, only recently have urgent pleas been made for systematic surveillance of drug usage and susMethods ceptibility trends to better delineate relationships between drug usage and susceptibility [1, 5, 8, 11] .
Description of the Institution
At first glance, it might seem that relating the intensity of
The Medical University of South Carolina hospital is a 600-antimicrobial usage and changes in susceptibility would be bed tertiary-care teaching institution, at which Ç400 beds are rather straightforward. However, establishing causality is utilized for nonpsychiatric adult inpatients. Intensive care units fraught with many confounding factors [10, 12, 13] . Despite within the adults' hospital include neurosurgical, surgical/ this, investigators have consistently reported an association betrauma, burn, cardiothoracic, medical, and cardiac units. Additween drug usage and susceptibility patterns [10, 14 -36] . Howtional specialized patient populations include oncology, carever, the focus of these studies was primarily on the use of a diac, renal, and bone marrow transplant patients. specific agent and how it related to the susceptibility of organisms to that agent alone. The impact of the use of multiple antimicrobials on the susceptibility pattern of the antimicrobial/ Data Collection organism of interest was frequently overlooked, except in a Census, antimicrobial usage, and susceptibility data for adult few studies [14, 26 -31, 35, 36] . These studies suggested that inpatients were collected from January 1992 through December usage of other agents was associated with the observed changes 1996. All data for the adults' hospital were collected on a quarterly basis and used to calculate annual totals, which were used for all subsequent analyses. Census data. The number of patient-days for the adults' patient's name, hospital location, order number, dose, dosing bility was calculated as the number of susceptible isolates divided by the total number of isolates and multiplied by 100. schedule (e.g., every 6 hours), and beginning and ending days of therapy were collected. The drug order number was used to identify any duplicate orders, which were removed from the Data Analysis database prior to subsequent analyses. Data were screened quarterly for completeness, with use of the order date. In cases Census data. The number of patient days were plotted against time to assess changes in the patient census. In addition, of missing data, the number of missing days per quarter was calculated and used to extrapolate the usage of all drugs in that these data were used to normalize antimicrobial usage data (g/patient-day) and the number of isolates (isolates/patient-day) quarter. Missing days represented only 9% of the total number of days over the entire study period.
to account for any changes due to variations in the patient census over the study period. Hospital-wide drug-usage data were collected for the antimicrobials listed in table 1. Oral drug usage data were included Antimicrobial usage data. Days of therapy were used when antimicrobial usage was compared, since g/patient-day are not for ciprofloxacin, ofloxacin, and trimethoprim-sulfamethoxazole (TMP-SMZ) in the calculation of total grams. All orders directly comparable, owing to differences in drug dosages. For each drug order, we calculated the days of therapy by subfor TMP-SMZ were converted to milligrams on the basis of the trimethoprim component with use of standard conversions tracting the beginning day from the ending day of therapy. As we were most interested in assessing relationships when for the intravenous and oral suspension products, respectively. No data for ofloxacin and piperacillin/tazobactam were availantibiotics were being used for therapeutic rather than prophylactic purposes, only those orders with §1 day of therapy were able prior to 1993 and 1994, respectively.
Susceptibility data. Susceptibility data were obtained for used. Data concerning orders with õ1 day of therapy (primarily preoperative doses) were excluded, as were those instances the following gram-negative aerobes isolated from hospitalized adult inpatients: Acinetobacter anitratus (baumannii), Enterofor which days of therapy could not be calculated because of incomplete or missing information. These orders (õ1 day of bacter aerogenes, Enterobacter cloacae, Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aerutherapy) comprised Ç8.5% of the total number of drug orders. The number of doses per day was derived from the dosing ginosa, and Serratia marcescens. All susceptibility results were categorized as susceptible according to the appropriate schedule (e.g., every 6 hours Å 4 doses/d). The total number of grams for each individual drug order was calculated from breakpoint concentrations, as established by the National Committee for Clinical Laboratory Standards during the study pethe dose, the total number of daily doses, and the length of therapy in days. Data for each drug were then summed and riod. With use of the Vitek automated susceptibility testing system (bioMérieux Vitek, Hazelwood, MO), susceptibility normalized by dividing the grams of each drug by the number of patient-days (g/patient-day). Days of therapy and g/patientwas determined by the department of clinical microbiology. Data from the Vitek system are electronically transferred to a day were plotted against time and assessed with simple linear regression to characterize changes over the study period. Only hospital mainframe computer that utilizes Cerner laboratory data management software. The Cerner software removes duthe direction (negative or positive) and not the magnitude of the slope was used to assess decreases or increases in drug plicate isolates that have been previously shown to alter susceptibility reports [37] . In this system, a duplicate isolate is defined usage. Susceptibility data. The number of isolates, number of isoas the same bacterial species from the same patient with the same susceptibility to a specific antimicrobial. All isolates lates/patient-day, and percentage of susceptibility over time were assessed by means of simple linear regression to charactested and all susceptible isolates were collected from all nonurine cultures for every adult inpatient. Percentage of susceptiterize overall trends for each organism during the study period.
/ 9c65$$my19 04-06-99 07:42:09 cida UC: CID during the study period. This criterion was chosen because it
likely represents a range of susceptibility that is clinically rele-
vant in antimicrobial decision-making in our institution. Of this
subset of data, only those relationships with a coefficient of Cephalosporins 34 determination (r 2 ) of at least 0.5 (corresponding to a correlation Cefazolin 15 (13 -16) coefficient of §0.70), based on simple linear regression, were further evaluated. Thus, the data utilized in this analysis were only for those individual antimicrobial/organism combinations Ceftriaxone 3 (2 -4) Cefuroxime 3 (3 -4) in which %S was §70% in any year and the r 2 for drug usage
vs. susceptibility linear regression was §0.5.
To assess the relationship between the use of an individual
agent and the pattern of susceptibility to it, the %S for each Aminoglycosides 17 antimicrobial/organism combination and normalized drug usGentamicin 11 (10 -12) Tobramycin 5 (4 -6) age for that antimicrobial (e.g., susceptibility of E. cloacae to
ceftazidime vs. ceftazidime, g/patient-day) over the entire study Fluoroquinolones 17 period were plotted and evaluated. To assess whether multiple Ciprofloxacin 16 (13 -18) antimicrobials were associated with the susceptibility of an
individual agent, simple linear regression was performed for were divided into two categories: (1) relationships in which drug usage increased and susceptibility decreased (FD, f%S) and (2) relationships in which drug usage decreased and suscepData for the individual agents are presented in table 2. The tibility increased (fD, F%S). Analysis of variance with Tukey's percentage of the total days of therapy increased (from 1992 standardized range post-hoc test (P õ .05) were used to assess values) in 1996, by 54% and 31% for the fluoroquinolones and differences in the number of relationships among drugs with miscellaneous agents, respectively, while it decreased slightly respect to their ability to affect organisms' susceptibility to for the penicillins (11%), cephalosporins (13%), and aminoglythem (e.g., susceptibility of K. pneumoniae to ceftriaxone vs. cosides (19%). Drug use (g/patient-day) increased for cefotaxceftriaxone, g/patient-day) as well as to other agents (e.g., susime, ciprofloxacin, imipenem, ofloxacin, TMP-SMZ, ampicilceptibility of K. pneumoniae to ceftazidime vs. ceftriaxone, lin/sulbactam, cefazolin, cefotetan, ceftazidime, cefuroxime, g/patient-day).
gentamicin, ticarcillin/clavulanate, tobramycin, and ceftriaxone. Decreased drug use (g/patient-day) was noted for amikacin, aztreonam, cefoxitin, ceftizoxime, piperacillin/tazobactam, ticarcillin, piperacillin, and ampicillin.
Results
The numbers of isolates tested for susceptibility during the Over the entire study period, the number of patient-days period studied are displayed in table 3. In general, the number decreased from 104,494 in 1992 to 95,411 in 1996. Patientof isolates increased for all organisms except E. coli. P. aerugidays steadily decreased from 1992 to 1995; however, a slight nosa was the most common organism, accounting for 25% of increase was observed from 1995 to 1996. The number of the total number of isolates over the entire study period. Alintensive care unit patient-days as a percentage of hospitalthough A. anitratus accounted for only Ç7% of all isolates wide patient-days was constant over the course of the study, from 1992 through 1996, the number of isolates per patientranging from 18% to 19% each year.
day increased steadily from 1994 through 1996. There was also Days of antibiotic therapy with the agents evaluated ina large increase in the number of S. marcescens and K. pneumoniae isolates over the study period. creased from 24,895 days in 1992 to 34,663 days in 1996.
/ 9c65$$my19 04-06-99 07:42:09 cida UC: CID Single-drug relationships. Twenty-three relationships that met the inclusion criteria, representing 15% of the number of single-drug/organism relationships evaluated, had a negative slope. Of these, 17 (74%) had increasing drug use and decreas- (figures 1 and 2). With the exception of cefotaxime, cefazolin, ceftriaxone, and cefotetan, for those drugs whose use increased, at least one relationship met our inclusion criteria. Although not organisms except E. cloacae. The relative frequency of these statistically significantly different from other agents, increasing relationships among organisms was as follows: A. anitratus ú ticarcillin/clavulanate use was associated with decreasing sus-P. aeruginosa Å K. pneumoniae ú E. aerogenes ú E. coli Å ceptibility for four of the eight organisms studied. For those S. marcescens Å P. mirabilis. drugs with decreasing use, only piperacillin, amikacin, aztreoMultiple-drug relationships. Of the 405 relationships with nam, and ticarcillin were associated with changes in susceptia negative slope that met our criteria, 75% were relationships bility to themselves. Drug-usage-vs.-susceptibility relationwith increasing drug use and decreasing susceptibility (FD, ships that met the inclusion criteria were observed with all f%S) and 25% were with decreasing drug use and increasing susceptibility (fD, F%S). The number of each type of relationship resulting from individual drug usage vs. susceptibility of other agents is displayed in figures 3 and 4. For individual bacterial species, a change in susceptibility occurred to a mean of 1.7 antibiotics (range, 0 -14) for the FD, f%S relationships and to a mean of 0.6 antibiotics (range, 0 -7) for the fD, F%S relationships. Where FD, f%S relationships were detected, ticarcillin/clavulanate, TMP-SMZ, and ceftazidime were most commonly associated with decreased susceptibility of another agent, despite each of these accounting for only 2% -4% of the total days of therapy. Conversely, increasing usage of imipenem and ciprofloxacin, which accounted for 10% and 16% of the total days of therapy, were associated less often with a decrease in susceptibility to other agents. For fD, F%S relation- evaluated was as follows: A. anitratus ú S. marcescens ú horizontal transmission of resistant isolates may obscure this relationship [9, 10, 32, 33] . Additionally, it should be recog-K. pneumoniae ú P. aeruginosa ú E. coli ú E. aerogenes ú nized that multiresistant organisms can be selected as a result P. mirabilis ú E. cloacae.
of the usage of antimicrobial agents unrelated to the agent of interest [18, 26] . Most studies have been on the relationship Discussion between an individual agent and its own susceptibility pattern. To date, limited data are available concerning the association In most studies, antimicrobial usage has been assumed to between the use of multiple antimicrobials and susceptibility be the major factor responsible for changes in susceptibility.
patterns. Although one would expect a strong relationship between antiIn a recent report, the effect of changes in the consumption microbial use and susceptibility patterns, other factors such as of macrolides on the susceptibility of group A streptococci to erythromycin in Finland was evaluated [21] . Macrolide use was restricted in response to a nationwide increase in erythromycin resistance. Following the implementation of the restriction policies, the number as well as the percentage of resistant isolates decreased. Data on the relative contributions of the individual agents to these decreases, however, were not reported. Stratton and co-workers tracked quinolone susceptibilities for P. aeruginosa during the process of replacing ciprofloxacin with ofloxacin [27]. The authors reported that a decrease in susceptibility was associated with an increase in the total usage of quinolones; however, it was not associated with the use of a specific agent. Similar results were reported following the evaluation of penicillin use and susceptibility over 7 years in a university hospital [29] . It was noted that penicillin consumption alone was not correlated with changes in susceptibility of S. aureus; susceptibility to other agents in the same class [36] . An interestPip Å piperacillin; Amp Å ampicillin; Pip/Taz Å piperacillin/tazobactam).
ing finding was that, as in our study, ticarcillin/clavulanate was / 9c65$$my19 04-06-99 07:42:09 cida UC: CID most frequently associated with decreases in susceptibility of õ70% may not be clinically relevant in empirical decisionmaking and therefore were not included. It is possible that other agents. White et al. assessed susceptibility trends of E. cloacae, S. marcescens, P. aeruginosa, and E. aerogenes to important relationships between susceptibility and drug usage may have occurred below this susceptibility cutoff. However, seven b-lactams and the relationship with usage of these agents over 7 years [14] . The relationship between ceftazidime use the majority of the relationships meeting our criteria (73% and 76% of the single-drug and multiple-drug relationships, and susceptibility of E. cloacae was poor (r õ 0.34). However, aztreonam usage was strongly correlated to the decrease in respectively) occurred with rates of susceptibility of §70%.
In addition, the rate of the development of resistance and susceptibility to ceftazidime for all organisms (r Å 0.84 -0.89). These reports illustrate the importance of including use of multhe point in that continuum at which one performs an evaluation may also hamper the ability to detect relationships between tiple drugs within the same drug class in the evaluation of susceptibility trends.
drug use and susceptibility. Should susceptibility change little, because of a ''lag phase'' or ''threshold'' effect or because Other investigators have reported on the influence of dissimilar agents on susceptibility patterns [20, 26, 28, 30, 31, 35] .
maximal declines in susceptibility have already occurred, one will not be able to detect a relationship, despite changing drug Chow et al. reported an increase in infections due to multiresistant Enterobacter species in patients having received prior theruse. This is illustrated by the relative lack of relationships observed with E. cloacae in the current study. Major decreases apy with a third-generation cephalosporin [26] . Resistance developed not only to other third-generation agents but also to in susceptibility of E. cloacae to cephalosporins had already occurred at our institution before 1992. Moreover, drug-usageextended-spectrum penicillins, chloramphenicol, tetracycline, norfloxacin, and TMP-SMZ. In contrast, Jacobson et al. did
vs.-susceptibility relationships involving decreased susceptibility are most likely found when the initial susceptibility is high, not demonstrate an association between the development of resistance to extended-spectrum cephalosporins and prior use as was the case with ofloxacin, ticarcillin/clavulanate, and ampicillin/sulbactam. of a number of different agents [20] . Søgaard demonstrated that the highest degree of correlation between antimicrobial
The time unit of observation is also an important consideration in these types of analyses. We utilized annual data in usage and resistance to a single antimicrobial was obtained when the usage of multiple agents was incorporated into the assessing relationships. Preliminary analysis of quarterly data revealed more fluctuations in drug-usage-and-susceptibility reanalysis [31] . Similar findings were reported by Møller in the evaluation lationships; however, this may simply be due to fewer observations being included in the percentage-susceptible calculations. of resistance of S. epidermidis, S. aureus, and E. coli to a variety of antimicrobials studied over a 7-year period [30] .
Although relationships that occur within a shorter time frame may be missed with the use of aggregate/annual data, one is Decreased resistance of Enterobacteriaceae and P. aeruginosa to aminoglycosides has been associated with decreases in cephless likely to be misled by relationships based on dramatically fluctuating data. alosporin use [28] . Substantial decreases in resistance to gentamicin and tobramycin (34% -85% and 35% -78%, respecFurthermore, most investigators utilize simple linear regression to characterize what may be nonlinear relationships [38] . tively) correlated well with decreased cephalosporin use. The authors hypothesized that the change in cephalosporin use, Simple linear regression may not be an optimal method for analyzing these types of data; however, it fit our data well either by itself or in conjunction with a marked increase in penicillin and erythromycin use, may have been responsible. since we evaluated the subset of drug-use-vs.-susceptibility relationships with an r 2 of §0.5. Since other factors may affect Other investigators have reported aminoglycoside use to be an independent predictor of resistance of P. aeruginosa to imisusceptibility patterns, explanation of at least 50% of the variability in the observed susceptibility trends was a reasonable penem and ceftazidime [35] . These data lend credence to the premise that the use of one class of agents might influence the objective. Others have suggested that a correlation coefficient of at least 0.7 is an appropriate marker for associations between resistance to dissimilar agents.
The present study also demonstrates that use of multiple drug use and susceptibility [17, 28, 30] . Currently, there is no consensus as to the magnitude of the correlation coefficient agents, similar and dissimilar, should be considered in evaluations of susceptibility trends. However, methodologic issues in that should be used in analyses of this type. As an additional consideration, in our study, had a correlation coefficient of 0.8 our study as well as in other studies deserve comment. In this study, we evaluated only those susceptibility data that were (r 2 Å 0.64) or 0.9 (r 2 Å 0.81) been used, this would have resulted in the exclusion of 76% and 86%, respectively, of our values of at least 70% susceptibility. We chose this cutoff because an analysis of prescribing trends at our institution data.
We focused on only those relationships with a negative demonstrated that disproportionate decreases in drug use occurred when susceptibility to a given agent decreased to õ70% slope, since this is what would likely draw the attention of most clinicians utilizing and evaluating these types of data. (authors' unpublished data). This suggests that prescribers tend not to use a drug empirically when its susceptibility declines We, like other investigators, did note occasions when the slope was positive (increasing drug usage with increasing susceptibilto õ70%. Thus, evaluation of susceptibility data for rates of / 9c65$$my19 04-06-99 07:42:09 cida UC: CID
